Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

NanoCarrier Co Ltd

+ Add to Watchlist

4571:JP

1,161.0 JPY 15.0 1.31%

As of 02:00:00 ET on 03/27/2015.

Snapshot for NanoCarrier Co Ltd (4571)

Open: 1,146.0 Day's Range: 1,146.0 - 1,182.0 Volume: 202,200
Previous Close: 1,146.0 52wk Range: 885.0 - 2,156.0 1-Yr Rtn: -17.83%

Stock Chart for 4571

No chart data available.
  • 4571:JP 1,162.0
  • 1D
  • 1M
  • 1Y
1,146.0
Interactive 4571 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4571

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. TPX -
Earnings Per Share (ttm) -11.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M JPY) 47,220.89
Shares Outstanding (M) 40.67
30 Day Average Volume 357,543
Price/Book (mrq) 3.4164
Price/Sale (ttm) 120.3979
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4571

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4571

NanoCarrier Co., Ltd. is a biotech company that utilizes micellar nanoparticle (polymeric micelles) technology for the production and development of pharmaceuticals focusing mainly on cancer therapies.

Ichiro NakatomiPresident/CEOTetsuhito MatsuyamaCFO/Head:President’s Office
Hiroyuki HanadaChief Operating Officer
More Company Profile & Key Executives for 4571

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil